Characteristics of tumor microenvironment and novel immunotherapeutic strategies for non-small cell lung cancer
{{output}}
Immune checkpoint inhibitor-based immunotherapy has revolutionized the treatment approach of non-small cell lung cancer (NSCLC). Monoclonal antibodies against programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) are widely used in clinical practice, but othe... ...
